Applied Molecular Transport Inc. (Nasdaq: AMTI), relating to its proposed sale to Cyclo Therapeutics, Inc. Under the terms of the agreement, AMTI shareholders are expected to receive 0.174 shares of Cyclo per share they own.
Applied Molecular Transport Inc. (Nasdaq: AMTI), relating to its proposed sale to Cyclo Therapeutics, Inc. Under the terms of the agreement, AMTI shareholders are expected to receive 0.174 shares of Cyclo per share they own.